Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of novel antibiotics to treat serious infections. Nabriva Therapeutics has two products: Xenleta (lefamulin), recently approved by the FDA for both Oral and IV use and CONTEPO (fosfomycin) for injection, we submitted an NDA for CONTEPO, a potential first-in-class epoxide antibiotic in the United States for complicated urinary tract infections (cUTIs) including acute pyelonephritis (AP). Our corporate headquarters are in Dublin, Ireland with offices and labs located in Vienna, Austria and King of Prussia, PA. Nabriva is a commercial-stage biopharmaceutical company with locations in the United States (King of Prussia, PA, San Diego, CA), Austria (Vienna), and Ireland (Dublin), home of our corporate headquarters.
View Top Employees from Nabriva Therapeutics plc| Website | http://www.nabriva.com |
| Ticker | NBRV |
| Revenue | $9 million |
| Funding | $92.2 million |
| Employees | 65 (65 on RocketReach) |
| Founded | 2006 |
| Address | 25-28 N Wall Quay Ifsc, Dublin, Leinster DUBLIN 1, IE |
| Phone | +353 1 649 2000 |
| Technologies |
JavaScript,
HTML,
Font Awesome
+39 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Drug Discovery, Healthcare, Science and Engineering, Health Care, Medical |
| Web Rank | 5 Million |
| Keywords | Nabriva Therapeutics, Ted Nabriva, Biothreat Organisms, Nabriva, Navbriva |
| Competitors | Melinta Therapeutics, ORIC Pharmaceuticals Inc., Otonomy, Inc, Pliant Therapeutics, Tetraphase Pharmaceuticals |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325414 Companies, NAICS Code 3254 Companies, NAICS Code 541711 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 54 Companies, NAICS Code 32541 Companies, NAICS Code 54171 Companies |
Looking for a particular Nabriva Therapeutics plc employee's phone or email?
Nabriva Therapeutics plc Questions
The Nabriva Therapeutics plc annual revenue was $9 million in 2024.
Thomas Lembck is the CIO of Nabriva Therapeutics plc.
65 people are employed at Nabriva Therapeutics plc.
Nabriva Therapeutics plc is based in Dublin, Leinster.
The NAICS codes for Nabriva Therapeutics plc are [325414, 3254, 541711, 5417, 541, 325, 32, 54, 32541, 54171].
The SIC codes for Nabriva Therapeutics plc are [283, 28].
Top Nabriva Therapeutics plc Employees
-
23
-
31
-
55+
-
View
Jodi VanDerveer
Senior Vice President, Head of Human Resources at Nabriva Therapeutics plc
Phoenixville, Pennsylvania, United States53 -
43
Related Companies
